2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Sandra Demaria, MD, assistant professor of Radiation Oncology, (Interim), Radiation Oncology, Weill Cornell Medical College and New-York Presbyterian, discusses the synergy with radiation therapy and immunotherapy as a potential combination regimen for patients with cancer.
Sandra Demaria, MD, assistant professor of Radiation Oncology, (Interim), Radiation Oncology, Weill Cornell Medical College and New-York Presbyterian, discusses the synergy with radiation therapy and immunotherapy as a potential combination regimen for patients with cancer.
Radiation therapy has various effects on patients depending on the way it is administered, Demaria explains. Nevertheless, there is a synergy that exists between radiation therapy and immunotherapy that has an effect on the tumor microenvironment.
Evidence suggests that T-cell responses can occur with such a combination, she adds, while ongoing research is examining additional immunotherapy and radiation therapy agents. This is particulary interesting, Demaria says, because radiation therapy is readily available; however, it could now be administered in a completely different way to induce a systemic effect on tumors.